John G. Freund's Insider Trades & SAST Disclosures
John G. Freund's most recent trade in SI-BONE Inc was a trade of 8,791 Common Stock done . Disclosure was reported to the exchange on June 26, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John G. Freund.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SI-BONE Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 8,791 | 34,626 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Collegium Pharmaceutical Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 7,693 | 52,468 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 20.54 per share. | 09 Aug 2023 | 30,000 | 103,899 (0%) | 0% | 20.5 | 616,197 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 4,866 | 25,835 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Collegium Pharmaceutical Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 9,792 | 44,775 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,324 | 20,969 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 18,500 | 18,500 | - | - | Stock Option (right to buy) | |
| Collegium Pharmaceutical Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 14,035 | 34,983 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 31.11 per share. | 14 Jun 2021 | 21,511 | 343,957 (1%) | 0% | 31.1 | 669,136 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 31.28 per share. | 14 Jun 2021 | 17,990 | 365,468 (1%) | 0% | 31.3 | 562,738 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 31.41 per share. | 14 Jun 2021 | 12,591 | 331,366 (1%) | 0% | 31.4 | 395,427 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 3,848 | 12,645 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 18,500 | 18,500 | - | - | Stock Option (right to buy) | |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 30.06 per share. | 27 May 2021 | 45,220 | 383,458 (1%) | 0% | 30.1 | 1,359,444 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 30.93 per share. | 27 May 2021 | 26,367 | 428,678 (1%) | 0% | 30.9 | 815,523 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 32.54 per share. | 24 May 2021 | 50,827 | 474,079 (1%) | 0% | 32.5 | 1,653,956 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 31.85 per share. | 24 May 2021 | 17,138 | 455,045 (1%) | 0% | 31.8 | 545,833 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 32.55 per share. | 24 May 2021 | 1,696 | 472,183 (1%) | 0% | 32.5 | 55,197 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 32.76 per share. | 24 May 2021 | 200 | 473,879 (1%) | 0% | 32.8 | 6,552 | Common Stock |
| Collegium Pharmaceutical Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 9,941 | 20,948 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 30.25 per share. | 16 Mar 2021 | 600,000 | 524,906 (2%) | 2% | 30.3 | 18,150,000 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 31.63 per share. | 16 Mar 2021 | 66,200 | 1,124,906 (4%) | 0% | 31.6 | 2,093,688 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 30.33 per share. | 16 Mar 2021 | 55,053 | 1,191,106 (4%) | 0% | 30.3 | 1,669,884 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 31.39 per share. | 11 Mar 2021 | 91,072 | 1,327,046 (5%) | 0% | 31.4 | 2,858,859 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 30.90 per share. | 11 Mar 2021 | 80,887 | 1,246,159 (4%) | 0% | 30.9 | 2,499,586 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 31.05 per share. | 11 Mar 2021 | 63,928 | 1,418,118 (5%) | 0% | 31.0 | 1,984,741 | Common Stock |
| Sutro Biopharma Inc | John G. Freund | Director | Other type of transaction at price $ 0.00 per share. | 10 Dec 2020 | 118,735 | 0 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | John G. Freund | Director | Other type of transaction at price $ 0.00 per share. | 10 Dec 2020 | 56,327 | 56,327 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 23.28 per share. | 02 Dec 2020 | 100,000 | 1,529,932 (6%) | 0% | 23.3 | 2,328,480 | Common Stock |
| SI-BONE Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 23.39 per share. | 02 Dec 2020 | 47,886 | 1,482,046 (5%) | 0% | 23.4 | 1,120,197 | Common Stock |
| Sutro Biopharma Inc | John G. Freund | Director | Other type of transaction at price $ 0.00 per share. | 09 Nov 2020 | 560,053 | 0 (0%) | 2% | 0 | Common Stock | |
| Sutro Biopharma Inc | John G. Freund | Director | Other type of transaction at price $ 0.00 per share. | 09 Nov 2020 | 118,735 | 118,735 (0%) | 0% | 0 | Common Stock | |
| SI-BONE Inc | John G. Freund | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 19 Oct 2020 | 190,053 | 2,129,932 (8%) | 0% | 22 | 4,181,166 | Common Stock |
| Sutro Biopharma Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 12.00 per share. | 18 Sep 2020 | 400,000 | 560,053 (2%) | 1% | 12 | 4,800,000 | Common Stock |
| Sutro Biopharma Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 11 Sep 2020 | 500,000 | 960,053 (4%) | 2% | 10 | 5,000,000 | Common Stock |
| Sutro Biopharma Inc | John G. Freund | Director | Sale of securities on an exchange or to another person at price $ 8.72 per share. | 19 Aug 2020 | 500,000 | 1,460,053 (6%) | 2% | 8.7 | 4,360,000 | Common Stock |
| SI-BONE Inc | John G. Freund | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 8,797 | 8,797 (0%) | 0% | 0 | Common Stock | |
| Sutro Biopharma Inc | John G. Freund | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 12,000 | 12,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges